Boston Scientific blue without tag
The Intracept Procedure by Relievant
  • Intracept
    • Intracept Overview
    • Basics
    • Vertebrogenic Pain
    • Procedure
    • System
  • Living Proof
    • Living Proof Overview
    • From Patients
    • From Physicians
    • Clinical Evidence
  • Resources
    • Resources Overview
    • Insurance Coverage
    • Physician Reimbursement
    • Modic Changes
  • Company
    • Company Overview
    • History
    • Careers
  • Find a Doctor
  • News & Events
Select Page

Relievant Medsystems Announces New Category I CPT Codes for Intracept® Procedure

by Jason Rutten | Dec 30, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today that new Category I Current Procedural Terminology (CPT) codes for the Intracept Procedure are in effect as of January 1, 2022....

Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Demonstrating Long-Term Relief for Chronic Low Back Pain 24 Months Post-Procedure

by Jason Rutten | Nov 29, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month results from a Level 1, prospective, randomized, multi-center trial (INTRACEPT) that further validate the safety,...

Relievant Medsystems Announces New Vertebrogenic Low Back Pain ICD-10 Diagnosis Code

by Jason Rutten | Sep 29, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth Revision,...

Relievant Medsystems Announces Appointment of Dave Amerson to Board of Directors

by Jason Rutten | Jul 1, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the appointment of Dave Amerson to the Company’s Board of Directors. “It is with great pleasure that I welcome Dave to our Board...

Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

by Jason Rutten | Jun 15, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 12-month results from a Level 1, prospective, randomized, multi-center trial that demonstrated the effectiveness and superiority...
« Older Entries

Recent Posts

  • Boston Scientific Announces Positive Noridian Local Coverage Determination for the Intracept™ Procedure
  • Relievant Medsystems Announces Positive Coverage Policy from Humana for the Intracept Procedure
  • Contraindications, Warnings, and Precautions
  • Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
  • Relievant Medsystems Introduces Intracept Simulator System Powered by Medability for Improved and Expanded Physician Training Opportunities

Recent Comments

No comments to show.
Relievant logo
  • Intracept
    • Intracept Overview
    • Basics
    • Vertebrogenic Pain
    • Procedure
    • System
  • Living Proof
    • Living Proof Overview
    • From Patients
    • From Physicians
    • From Clinical Trials
  • Resources
    • Resources Overview
    • Insurance Coverage
    • Physician Reimbursement
    • Modic Changes
  • Company
    • Company Overview
    • History
    • Careers

Contact:

Boston Scientific
7201 Metro Blvd #300
Edina, MN 55439
650-368-1000

 

Development and Operations
1230 Midas Way, Suite 200
Sunnyvale, CA 94085

Contact Us
Follow Us:
  • Follow
  • Follow
  • Follow
  • Follow
Copyright © 2025 by Boston Scientific Corporation or its affiliates. All rights reserved.

Terms of Use Privacy Policy
Do not sell or share my personal information